Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: A retrospective, population-based cohort study.
Adult
Age Factors
Anti-HIV Agents
/ therapeutic use
Female
Follow-Up Studies
HIV
/ isolation & purification
HIV Infections
/ drug therapy
Humans
Male
Medication Adherence
/ statistics & numerical data
Middle Aged
Ontario
Patient Participation
/ statistics & numerical data
Retrospective Studies
Sex Factors
Time Factors
Viral Load
/ statistics & numerical data
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
22
06
2018
accepted:
16
12
2018
entrez:
5
1
2019
pubmed:
5
1
2019
medline:
1
10
2019
Statut:
epublish
Résumé
The HIV cascade is an important framework for assessing systems of care, but population-based assessment is lacking for most jurisdictions worldwide. We measured cascade indicators over time in a population-based cohort of diagnosed people living with HIV (PLWH) in Ontario, Canada. We created a retrospective cohort of diagnosed PLWH using a centralized laboratory database with HIV diagnostic and viral load (VL) test records linked at the individual-level. Individuals enter the cohort with record of a nominal HIV-positive diagnostic test or VL test, and remain unless administratively lost to follow-up (LTFU, >2 consecutive years with no VL test and no VL test in later years). We calculated the annual percent of diagnosed PLWH (cohort individuals not LTFU) between 2000 and 2015 who were in care (≥1 VL test), on ART (as documented on VL test requisition) or virally suppressed (<200 copies/ml). We also calculated time from diagnosis to linkage to care and viral suppression among individuals newly diagnosed with HIV. Analyses were stratified by sex and age. Upper/lower bounds were calculated using alternative indicator definitions. The number of diagnosed PLWH increased from 8,859 (8,859-11,389) in 2000 to 16,110 (16,110-17,423) in 2015. Over this 16-year period, the percent of diagnosed PLWH who were: in care increased from 81% (63-81%) to 87% (81-87%), on ART increased from 55% (34-60%) to 81% (70-82%) and virally suppressed increased from 41% (23-46%) to 80% (67-81%). Between 2000 and 2014, the percent of newly diagnosed individuals who linked to care within three months of diagnosis or achieved viral suppression within six months of diagnosis increased from 67% to 82% and from 22% to 42%, respectively. Estimates were generally lower for females and younger individuals. HIV cascade indicators among diagnosed PLWH in Ontario improved between 2000 and 2015, but gaps still remain-particularly for younger individuals.
Sections du résumé
BACKGROUND
The HIV cascade is an important framework for assessing systems of care, but population-based assessment is lacking for most jurisdictions worldwide. We measured cascade indicators over time in a population-based cohort of diagnosed people living with HIV (PLWH) in Ontario, Canada.
METHODS
We created a retrospective cohort of diagnosed PLWH using a centralized laboratory database with HIV diagnostic and viral load (VL) test records linked at the individual-level. Individuals enter the cohort with record of a nominal HIV-positive diagnostic test or VL test, and remain unless administratively lost to follow-up (LTFU, >2 consecutive years with no VL test and no VL test in later years). We calculated the annual percent of diagnosed PLWH (cohort individuals not LTFU) between 2000 and 2015 who were in care (≥1 VL test), on ART (as documented on VL test requisition) or virally suppressed (<200 copies/ml). We also calculated time from diagnosis to linkage to care and viral suppression among individuals newly diagnosed with HIV. Analyses were stratified by sex and age. Upper/lower bounds were calculated using alternative indicator definitions.
RESULTS
The number of diagnosed PLWH increased from 8,859 (8,859-11,389) in 2000 to 16,110 (16,110-17,423) in 2015. Over this 16-year period, the percent of diagnosed PLWH who were: in care increased from 81% (63-81%) to 87% (81-87%), on ART increased from 55% (34-60%) to 81% (70-82%) and virally suppressed increased from 41% (23-46%) to 80% (67-81%). Between 2000 and 2014, the percent of newly diagnosed individuals who linked to care within three months of diagnosis or achieved viral suppression within six months of diagnosis increased from 67% to 82% and from 22% to 42%, respectively. Estimates were generally lower for females and younger individuals.
DISCUSSION
HIV cascade indicators among diagnosed PLWH in Ontario improved between 2000 and 2015, but gaps still remain-particularly for younger individuals.
Identifiants
pubmed: 30608962
doi: 10.1371/journal.pone.0210096
pii: PONE-D-18-18733
pmc: PMC6319701
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0210096Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Epidemiol. 2015 Nov;68(11):1301-11
pubmed: 25835491
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
AIDS. 2016 Sep 10;30(14):2227-34
pubmed: 27314178
Curr Opin HIV AIDS. 2016 Jan;11(1):102-8
pubmed: 26545266
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):351-8
pubmed: 25501613
PLoS One. 2011;6(6):e21748
pubmed: 21738786
Sex Transm Dis. 2014 Jan;41(1):41-2
pubmed: 24326580
J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):129-32
pubmed: 24121761
J Adolesc Health. 2012 Dec;51(6):551-6
pubmed: 23174464
AIDS. 2015 Nov 28;29(18):2509-15
pubmed: 26372488
J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):217-26
pubmed: 25394192
J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):323-30
pubmed: 25140904
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):348-355
pubmed: 27351889
J Int AIDS Soc. 2015 Nov 30;18:20634
pubmed: 26626715
J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):474-80
pubmed: 25835603
MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1113-7
pubmed: 25426654
Ann Epidemiol. 2015 Apr;25(4):226-30
pubmed: 25727312
Ann Intern Med. 2012 Sep 4;157(5):325-35
pubmed: 22944874
Int J Epidemiol. 2013 Apr;42(2):402-11
pubmed: 22345312
J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):489-94
pubmed: 26258570
J Clin Epidemiol. 2012 Feb;65(2):126-31
pubmed: 22075111
Can J Public Health. 2005 Jul-Aug;96(4):308-12
pubmed: 16625804
AIDS Patient Care STDS. 2015 Nov;29(11):582-90
pubmed: 26505968
Sex Transm Dis. 2016 Jan;43(1):34-40
pubmed: 26650994
BMC Infect Dis. 2015 Nov 03;15:496
pubmed: 26530500
PLoS One. 2015 Jun 18;10(6):e0129376
pubmed: 26086089
Am J Public Health. 2014 Sep;104(9):e24-9
pubmed: 25033144
Lancet HIV. 2015 Jun;2(6):e225-6
pubmed: 26423191
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S228-32
pubmed: 23764640
Clin Infect Dis. 2016 Mar 1;62(5):648-654
pubmed: 26567263
Lancet Infect Dis. 2014 Jan;14(1):40-49
pubmed: 24076277
J Int AIDS Soc. 2017 May 16;20(Suppl 3):21490
pubmed: 28530041
J Int AIDS Soc. 2015 Mar 02;18:19395
pubmed: 25735869
CMAJ Open. 2018 Nov 27;6(4):E551-E560
pubmed: 30482757
AIDS Care. 2015;27(12):1449-54
pubmed: 26605781
Science. 2013 Feb 22;339(6122):966-71
pubmed: 23430656
J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e10-9
pubmed: 26322672
AIDS. 2015 Aug 24;29(13):1681-9
pubmed: 26372279
Curr HIV/AIDS Rep. 2014 Dec;11(4):496-504
pubmed: 25384357
J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):299-306
pubmed: 23572013
Lancet. 2006 Aug 5;368(9534):531-6
pubmed: 16890841
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):531-539
pubmed: 27851713
PLoS One. 2013 Aug 15;8(8):e72257
pubmed: 23967292
AIDS Care. 2017 Jul;29(7):828-837
pubmed: 28027668
PLoS One. 2014 Dec 26;9(12):e115277
pubmed: 25541682
Clin Infect Dis. 2011 Mar 15;52(6):793-800
pubmed: 21367734
HIV Med. 2015 Jan;16(1):62-6
pubmed: 24919923
Curr Opin HIV AIDS. 2012 Nov;7(6):579-86
pubmed: 23076123
BMC Med Res Methodol. 2013 Mar 05;13:31
pubmed: 23496868
Open Med. 2013 Oct 22;7(4):e98-106
pubmed: 25237406